An Investment Case for Lateral Flow Assays (LFAs) for Neglected Tropical Diseases (NTD)

Ultrasensitive antigen tests are needed for early detection of numerous infectious diseases, and for surveillance and monitoring progress towards disease elimination. GHIG and IDC/LSHTM worked with the Global Good Fund and Intellectual Ventures Laboratory to understand how to improve and expand LFA technologies to a wide range of infectious and potentially non-infectious diseases with high burden in low-and middle-income countries; particularly for the neglected tropical diseases (NTDs).